Profil
Michael Broxson is currently a Director at Molecular Templates OpCo, Inc. and a Vice President, Head-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. He was previously the Chief Executive Officer at Q32 Bio, Inc. and a Director at Molecular Templates, Inc. Broxson received an undergraduate degree from Tulane University (Louisiana) and an MBA degree from The University of Chicago Booth School of Business.
Aktive Positionen von Michael Broxson
| Unternehmen | Position | Beginn |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | - |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Broxson
| Unternehmen | Position | Ende |
|---|---|---|
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Vorstandsvorsitzender | 20.09.2022 |
| MOLECULAR TEMPLATES, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Michael Broxson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
















